نتائج البحث 311-320 من 4033 لعملية البحث عن 3-day reset
This Phase 3 ... The aim of this study is to study the efficacy and safety of our short and long one-day ... توجّه للصفحة 33 · توجّه للصفحة 44 · توجّه للصفحة 55 ...
... (3) Cohort 3 focuses on glioblastoma multiforme ... days prior to the end of the current therapy ... days prior to the collection. Pre-myeloid Cancer ...
... 3 participants will also complete amyloid- and tau-PET/CT scans. A Study to Compare Two Ultrasound-based Methods for Assessing Diaphragm Muscle Function.
One intiative was designed to implement a same day discharge for patients undergoing mastectomy with or without alloplastic reconstruction. This study aims to ...
The purpose of this study is to evaluate the safety and effectiveness of deep brain stimulation (DBS) of the dentate nucleus area for improving functional ...
Eligible patients presenting with apparent uterine confined grade 1, 2, or 3 endometrioid endometrial cancer will undergo standard-of-care primary surgical ...
... days after hospitalization. Finally, it will ... 3 meningioma as measured by 6-month PFS rate. ... days after hospitalization. Finally, it will allow ...
... Day 1 and bendamustine infusions (70 mg/m2) on Days 1 and 2 of each 28-day cycle. Patients in the GDC-0199+R arm will continue GDC-0199 treatment until ...
... 3 meningioma as measured by 6-month PFS rate. Medical and Resource Facilitation Intervention After Traumatic Brain Injury (MRFI). Rochester, Minn. The ...
A Phase 3 Efficacy and Safety Study of Pitolisant in Patients with Prader-Willi Syndrome. Rochester, Minn. The purpose of this study is to evaluate the ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.